Latest Regulatory Milestones News

St Barbara Limited is on track to complete key transactions with Lingbao Gold Group and Kumul Mineral Holdings, unlocking A$370 million in cash and advancing the New Simberi Gold Project.

Insignia Financial has secured a crucial regulatory approval from APRA, advancing the proposed acquisition by Daintree BidCo. The deal now moves closer to a shareholder vote scheduled for mid-April.

Memphasys Limited confirms uninterrupted operations across the Middle East and North Africa, securing new orders and advancing regulatory approvals despite ongoing regional tensions.

Vita Resources has secured a pivotal recommendation from Yukon authorities to proceed with a five-year exploration program at its ICE Copper-Gold Project, marking a significant step forward in its Canadian mining ambitions.

Imricor Medical Systems has filed a Form 10 registration with the U.S. SEC, marking its transition to a U.S. reporting company amid ongoing FDA clearances and clinical trials. This move signals a significant step in its early commercialisation of MRI-guided cardiac ablation technology.

Iron Bear Resources has received crucial exploration approvals from Newfoundland authorities, paving the way for a major drilling program aimed at expanding its vast iron ore resource in partnership with Vale S.A.

Viridis Mining and Minerals has raised AU$25 million through a heavily oversubscribed placement, bolstering its cash position to approximately AU$76 million as it advances the Colossus Rare Earth Project towards a Final Investment Decision in Q3 2026.

Ark Mines Limited has secured a crucial mining licence for its Sandy Mitchell Rare Earths Project in North Queensland, marking a key step toward development and commercialisation.

New Frontier Minerals has secured technical approval for its Mining Lease Application at the Big One Copper Deposit, setting the stage for potential near-term copper production amid a tightening global copper market.

Chariot Resources has raised $2.15 million in a well-supported placement to fund its acquisition and exploration of lithium assets in Nigeria, signalling strong investor confidence amid soaring lithium prices.

EMVision Medical Devices has secured a $3.8 million R&D tax rebate and gained approval to claim rebates on overseas expenditures, strengthening its financial footing as it advances clinical trials for its neurodiagnostic device.

Cobram Estate Olives has secured US Department of Justice approval for its acquisition of California Olive Ranch, paving the way for completion by late March 2026.